Puma Biotechnology | PBYI - 当期純利益





当期純利益 変化する 日付
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 210.47M 34.06M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Incyte USD 303.33M 4.05M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
Moderna USD -1.34B 517M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY -24.32B 127.96B 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03